https://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223378.%255BKeynote%2BSession%255D%2BCurrent%2BStatus%2Band%2BPromise%2Bof%2BmRNA%2BBiotherapeutics.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223395.%255BTechnical%2BSession%2B04%255D%2BGLP-1%253A%2BExpansion%2Bfrom%2BDiabetes%2Bto%2BObesity%252C%2BHeart%2BDisease%2Band%2BParkinson%2527s.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223382.%255BTechnical%2BSession%2B01%255D%2BPublic%2BFund%2BManagement%2BStrategies%2Bby%2BDomestic%2BVCs.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223387.%255BTechnical%2BSession%2B02%255D%2BInnovation%2Bin%2BmRNA%2BBiotherapeutics%2BManufacturing%2B%2540MIT.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223653.%255BInsight%2BSession%2B03%255D%2BLONZA.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223396.%255BTechnical%2BSession%2B05%255D%2BEmerging%2BIssues%2Band%2BHot%2BTopics%2Bfrom%2BFDA%2BCompliance%2Band%2BRegulatory%2BPerspective.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223651.%255BInsight%2BSession%2B01%255D%2BMERCK.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223694.%255BInsight%2BSession%2B04%255D%2BEnvirotainer.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223652.%255BInsight%2BSession%2B02%255D%2BSartorius.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223397.%255BTechnical%2BSession%2B06%255D%2BRegulatory%2BAffairs%2Bfor%2BClinical%2BTrials%2Bin%2BEurope.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223392.%255BTechnical%2BSession%2B03%255D%2BIntelligent%2BStrategies%2Bfor%2BDrug%2B%2526%2BMedical%2BDevice%2BDevelopment%2Bfrom%2BClinicians%25E2%2580%2599%2BPerspective.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223687.%255BInsight%2BSession%2B08%255D%2BAcrobiosystems.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223650.%255BTechnical%2BSession%2B07%255D%2BBIO%2BUSA%2B2024%2BDEBRIEFING.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223684.%255BInsight%2BSession%2B05%255D%2BIQVIA.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223688.%255BInsight%2BSession%2B09%255D%2BSAMSUNG%2BBIOLOGICS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223398.%255BTechnical%2BSession%2B08%255D%2BInnovation%2Band%2BInvestment%2BOpportunities%2Bin%2BMASH.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223404.%255BTechnical%2BSession%2B12%255D%2BTrailblazing%2Bdeals%2Bin%2Bthe%2Bhealthcare%2Bindustry.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223399.%255BTechnical%2BSession%2B09%255D%2B2030%2BGlobal%2BBD%2BPartnering%2BTREND%2BREPORT.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223412.%255BTechnical%2BSession%2B13%255D%2BGlobal%2BPre-commercialization%2BStrategy%2Bfor%2BKorea%2BBiotechs.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223685.%255BInsight%2BSession%2B06%255D%2BSolventum.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223689.%255BInsight%2BSession%2B10%255D%2BThermo%2BFisher%2BScientific.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223400.%255BTechnical%2BSession%2B10%255D%2BExplore%2Binto%2BGlobal%2BIPO%2BOpportunities.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223686.%255BInsight%2BSession%2B07%255D%2BSAMSUNG%2BBIOEPIS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223690.%255BInsight%2BSession%2B11%255D%2BBD.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223402.%255BTechnical%2BSession%2B11%255D%2BUpscaling%2Bthe%2BKorean%2BBIO%2BMPE%2B%2528BIO%2BMaterials%252C%2BParts%2Band%2BEquipment%2529%2BMarket.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223414.%255BTechnical%2BSession%2B14%255D%2BEntry%2BStrategies%2Bto%2Bthe%2BLeading%2BBio%2BMarkets.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223415.%255BTechnical%2BSession%2B15%255D%2BStart%2Bmanaging%2Byour%2Bhealth%2Bwith%2Bgene%2Banalysis.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223419.%255BTechnical%2BSession%2B19%255D%2BCultivated%2BMeat%253A%2BPromise%2Bof%2BFuture%2BFood%2BSecurity.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223416.%255BTechnical%2BSession%2B16%255D%2BNew%2BModels%2Bfor%2BSuccessful%2BBio-healthcare%2BStartups.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223417.%255BTechnical%2BSession%2B17%255D%2BWhat%2BMakes%2BKorean%2BBio-health%2BAttractive%2Bfor%2BForeign%2BInvestors%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223420.%255BTechnical%2BSession%2B20%255D%2BOutlook%2Bon%2Bthe%2BFuture%2Bof%2BDigital%2BHealthcare%2Bin%2Bthe%2BEra%2Bof%2BGenerative%2BAI.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223691.%255BInsight%2BSession%2B12%255D%2BIDBS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223692.%255BInsight%2BSession%2B13%255D%2B%2BWest%2BPharmaceutical.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223418.%255BTechnical%2BSession%2B18%255D%2BNewest%2BCGT%2Btechnologies%2Bfor%2Bwinning%2Bthe%2Bwar%2Bon%2Bcancer.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223421.%255BTechnical%2BSession%2B21%255D%2BU.S%2Bthe%2BLand%2Bof%2BOpportunity%2Bfor%2BRemote%2BHealthcare%2BBusiness.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277063.Opening%2BCeremony.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277064.%255BKeynote%2BSession%2B01%255D%2BHuman%2BStem%2BCells%253A%2BTransforming%2Bthe%2BFight%2BAgainst%2BNervous%2BSystem%2BDisease.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277065.%255BTechnical%2BSession%2B01%255D%2BFrom%2BAlgorithms%2Bto%2BImpact%253A%2BAI-Driven%2BDecision-Making%2Bin%2BBiopharma.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277072.%255BTechnical%2BSession%2B02%255D%2BRadiopharmaceuticals%2Bin%2BKorea%253A%2BWho%2BCan%2BActually%2BMake%2Ba%2BDeal%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277066.%255BTechnical%2BSession%2B03%255D%2BOrbit%2Bto%2BOutcomes%253A%2BThe%2BFuture%2Bof%2BSpace-enabled%2BBiopharma.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277073.%255BTechnical%2BSession%2B04%255D%2BAsia%2BIs%2BNot%2Ba%2BCategory%253A%2BBiotech%2BReshaping%2Bthe%2BGlobal%2BGame.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277067.%255BInsight%2BSession%2B01%255D%2BThermo%2BFisher%2BScientific.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277074.%255BInsight%2BSession%2B02%255D%2BIQVIA.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277068.%255BInsight%2BSession%2B03%255D%2BAlfa%2BLaval.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277069.%255BTechnical%2BSession%2B05%255D%2BBeauty%2BWas%2BNever%2BJust%2BCosmetics%253A%2BFrom%2BRetinol%2Bto%2BSecretome%252C%2BHow%2BBiology%2BIs%2BRewriting%2BBeauty.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277075.%255BTechnical%2BSession%2B06%255D%2BAutoimmune%2BBiologics%253A%2BWhy%2BSome%2BAssets%2BGet%2BFunded%2B%25E2%2580%2594%2Band%2BMost%2BDon%25E2%2580%2599t%2B%25E2%2580%2593%2BFrom%2BMass%2BIndications%2Bto%2BHigh-Value%2BTargets.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277070.%255BInsight%2BSession%2B05%255D%2BSamsung%2BBiologics.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277886.%255BInsight%2BSession%2B06%255D%2509Toursynbio.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277071.%255BTechnical%2BSession%2B07%255D%2BCan%2BKorean%2BBiotech%2BWin%2Bin%2BEurope%253F%2BWhat%2BIt%2BTakes%2Bto%2BPartner%2Band%2BScale.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277076.%255BTechnical%2BSession%2B08%255D%2BPost-GLP-1%253A%2BWho%2BWill%2BLead%2Bthe%2BNext%2BExpansion%2Bof%2Bthe%2BObesity%2BMarket%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277077.%255BKeynote%2BSession%2B02%255D%2BWhen%2BBig%2BPharma%2BComes%2BKnocking.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277084.%255BTechnical%2BSession%2B09%255D%2BConnected%2BCare%253A%2BBeyond%2Bthe%2BHospital%252C%2BBeyond%2Bthe%2BDevice.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277089.%255BInsight%2BSession%2B07%255D%2BSartorius.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277083.%255BInsight%2BSession%2B08%255D%2BMerck.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277088.%255BTechnical%2BSession%2B10%255D%2BNewCo%2BIs%2BNo%2BLonger%2BOptional%253A%2BHow%2Bto%2BMake%2BIt%2BWork.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277082.%255BTechnical%2BSession%2B11%255D%2BNavigating%2BFDA%25E2%2580%2599s%2BEvolving%2BPriorities%253A%2BWhat%2BKorean%2BLife%2BSciences%2BCompanies%2BNeed%2Bto%2BKnow.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277081.%255BLuncheon%2BSession%255D%2BECOLAB.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277087.%255BTechnical%2BSession%2B12%255D%2BWould%2BYou%2BWrite%2Bthe%2BCheck%253F%2BThe%2BGlobal%2BInvestor%2BTake%2Bon%2BKorean%2BBiotech.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277080.%255BTechnical%2BSession%2B13%255D%2BOne%2BPipeline%252C%2BTwo%2BMarkets%253A%2BDual%2BCommercialization%2BStrategies%2BThrough%2BAnimal%2BHealth.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277079.%255BInsight%2BSession%2B09%255D%2BBD.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277086.%255BTechnical%2BSession%2B16%255D%2BFood%2Bas%2BMedicine%2B-%2BUnlocking%2Bthe%2BNext%2BFrontier%2Bof%2BPreventive%2BHealth%2Bthrough%2BBiotechnology.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277078.%255BTechnical%2BSession%2B14%255D%2BWhy%2BGreat%2BDeals%2BFall%2BApart%2B-%2Band%2BWhy%2BSigned%2BDeals%2BStill%2BGo%2BWrong.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277085.%255BTechnical%2BSession%2B17%255D%2BScaling%2BPharma%2BCold%2BChains%253A%2BFrom%2BClinical%2BDevelopment%2Bto%2BGlobal%2BCommercialization.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277888.%255BTechnical%2BSession%2B15%255D%2BWhy%2BGreat%2BDeals%2BFall%2BApart%2B-%2Band%2BWhy%2BSigned%2BDeals%2BStill%2BGo%2BWrong.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277090.%255BTechnical%2BSession%2B18%255D%2BFrom%2BNeural%2BSignal%2Bto%2BMarket%2BSignal.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277092.Possibility%2BNeurotechnologies%2B-%2BThe%2BFuture%2Bof%2BAccessible%2BHuman%25E2%2580%2593Technology%2BInteraction.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.5267.277091.%255BTechnical%2BSession%2B19%255D%2BWe%2BAll%2BHave%2BAI.%2BNow%2BWhat%253F%253A%2BBuilding%2BReal%2BValue%2Bin%2BAI%2BDrug%2BDiscovery.html